BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11363377)

  • 1. The first integrase inhibitor.
    Smart T
    GMHC Treat Issues; 1996 Jan; 10(1):8-9. PubMed ID: 11363377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.
    Robinson WE; Reinecke MG; Abdel-Malek S; Jia Q; Chow SA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6326-31. PubMed ID: 8692814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
    Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
    Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules.
    Farnet CM; Wang B; Lipford JR; Bushman FD
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9742-7. PubMed ID: 8790401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.
    Puras Lutzke RA; Eppens NA; Weber PA; Houghten RA; Plasterk RH
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11456-60. PubMed ID: 8524782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
    Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
    J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New wave antiretrovirals.
    Smart T
    GMHC Treat Issues; 1996 Sep; 10(9):1-3. PubMed ID: 11363838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
    Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
    Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV integrase structure catalyzes drug search.
    O'Brien C
    Science; 1994 Dec; 266(5193):1946. PubMed ID: 7801119
    [No Abstract]   [Full Text] [Related]  

  • 10. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
    Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
    J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of human immunodeficiency virus integrase.
    Fesen MR; Kohn KW; Leteurtre F; Pommier Y
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2399-403. PubMed ID: 8460151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex.
    Mazumder A; Gupta M; Perrin DM; Sigman DS; Rabinovitz M; Pommier Y
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):115-25. PubMed ID: 7734185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; QuiƱones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New targets for inhibitors of HIV-1 replication.
    Moore JP; Stevenson M
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening.
    Caumont AB; Jamieson GA; Pichuantes S; Nguyen AT; Litvak S; Dupont C
    Curr Genet; 1996 May; 29(6):503-10. PubMed ID: 8662188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.
    Eich E; Pertz H; Kaloga M; Schulz J; Fesen MR; Mazumder A; Pommier Y
    J Med Chem; 1996 Jan; 39(1):86-95. PubMed ID: 8568830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in anti-HIV structure-based drug design.
    Gait MJ; Karn J
    Trends Biotechnol; 1995 Oct; 13(10):430-8. PubMed ID: 7546568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type-1 integrase by curcumin.
    Mazumder A; Raghavan K; Weinstein J; Kohn KW; Pommier Y
    Biochem Pharmacol; 1995 Apr; 49(8):1165-70. PubMed ID: 7748198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hunt for HIV-1 integrase inhibitors.
    Lataillade M; Kozal MJ
    AIDS Patient Care STDS; 2006 Jul; 20(7):489-501. PubMed ID: 16839248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.